Trials / Conditions / Corneal Endothelial Dystrophy
Corneal Endothelial Dystrophy
7 registered clinical trials studyying Corneal Endothelial Dystrophy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Assess Safety and Tolerability of Multiple Doses of EO2002 NCT05636579 | Asociación para Evitar la Ceguera en México | Phase 1 |
| Completed | A Safety and Efficacy Trial of TTHX1114 in People With CED NCT04812067 | Trefoil Therapeutics, Inc. | Phase 2 |
| Completed | Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection NCT05136443 | Price Vision Group | Phase 4 |
| Completed | Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema NCT04894110 | Emmecell | Phase 1 |
| Completed | A Phase 1/ Phase 2 Study of TTHX1114(NM141) NCT04520321 | Trefoil Therapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy NCT03575130 | University of Erlangen-Nürnberg Medical School | Phase 2 |
| Unknown | Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema NCT04191629 | Valeria Sanchez-Huerta | Phase 1 |